Shannon Campbell

Shannon Campbell has served as Chief Commercial Officer since February 2022. She is responsible for the global commercialization strategy and activity at Merus. Ms. Campbell has over 25 years of pharmaceutical commercialization experience across a wide range of geographies, markets and product lifecycles. She’s successfully led 25+ specialty brands, including 11 new chemical entity launches across key markets and regions globally. Ms. Campbell most recently led the U.S. Solid Tumor Franchise at Novartis Pharmaceuticals Corporation where she was responsible for a broad portfolio of oncology and rare disease products. During her time there, she led diverse teams and drove strong commercial execution including multiple launches that changed the standard of care in breast and targeted lung cancers. Prior to Novartis, Ms. Campbell helped to build, launch and subsequently lead Bayer HealthCare Pharmaceuticals US Oncology Business Unit. Prior to Bayer, she held positions of increasing responsibility at Abbott Labs and the Pharmacia heritage companies (Pharmacia & Upjohn, The Upjohn Company).

Ms. Campbell holds a Bachelor of Science degree from Ithaca College, and completed several advanced leadership, strategy and finance programs at the University of Michigan Ross School of Business, IMD, Harvard Business School and Wharton.